NVCT Highlights NXP200 Glioma Data Featuring Complete Responses and 95% 12-Month Survival in High-Grade Patients
Market Chameleon (Mon, 26-Oct 11:41 AM)
Nuvectis Secures $115M Funding and Advances Late-Stage Pipeline With Ciprocopan's First Global Approval
Market Chameleon (Tue, 4-Aug 9:19 AM)
